Feng Chi Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	13.23	26.25	30.61	65.9	48.81	47.28
Short-Term Investments	178.35	180.93	185.32	169	181.47	171.98
Cash & Short-Term Investments	191.59	207.18	215.93	234.9	230.27	219.26
Cash Growth	-12.21%	-4.06%	-8.08%	2.01%	5.03%	9.63%
Accounts Receivable	22.02	15.92	14.92	11.54	12.61	13.03
Receivables	22.02	15.92	14.92	11.54	12.61	13.03
Inventory	31.41	19.05	19.04	25.46	20.33	26.95
Prepaid Expenses	1.24	3.27	3.17	0.85	1.16	0.71
Other Current Assets	0.68	0.91	2.15	2.47	1.67	1.64
Total Current Assets	246.94	246.32	255.21	275.22	266.03	261.59
Property, Plant & Equipment	38.92	32.53	27.24	24.29	13.42	15.92
Long-Term Investments	11.98	12.78	11.33	-	-	-
Other Intangible Assets	0.05	0.02	0.07	0.13	0.01	0.02
Long-Term Deferred Tax Assets	1.58	1.51	1.67	1.63	1.72	1.53
Other Long-Term Assets	5.83	5.92	5.52	7.1	5.51	4.92
Total Assets	305.31	299.07	301.03	308.36	286.69	283.99
Accounts Payable	15.81	17.07	12.94	18.78	14.9	14.19
Accrued Expenses	5.48	6.21	8.08	9.3	8.59	8.95
Current Portion of Leases	2.76	2.72	2.65	2.58	2.55	2.71
Current Income Taxes Payable	2.45	0.18	1.71	2.33	2.17	2.59
Current Unearned Revenue	21.89	22.29	24.17	25.24	23.97	24.8
Other Current Liabilities	19.57	5.13	5.25	3.3	4	3.13
Total Current Liabilities	67.95	53.59	54.8	61.53	56.18	56.36
Long-Term Leases	4.04	5.43	8.15	10.8	-	2.55
Long-Term Deferred Tax Liabilities	0.03	0.18	0.09	0.16	-	-
Total Liabilities	72.02	59.19	63.03	72.49	56.18	58.91
Common Stock	154	154	154	154	154	154
Additional Paid-In Capital	30.05	30.05	30.05	30.05	30.05	30.05
Retained Earnings	48.45	54.24	53.82	51.82	46.45	41.03
Comprehensive Income & Other	0.78	1.58	0.13	-	-	-
Shareholders' Equity	233.29	239.88	238	235.87	230.51	225.08
Total Liabilities & Equity	305.31	299.07	301.03	308.36	286.69	283.99
Total Debt	6.8	8.15	10.8	13.38	2.55	5.26
Net Cash (Debt)	184.79	199.03	205.13	221.53	227.72	213.99
Net Cash Growth	-11.48%	-2.98%	-7.40%	-2.72%	6.42%	11.40%
Net Cash Per Share	11.96	12.87	13.27	14.32	14.73	13.85
Filing Date Shares Outstanding	15.4	15.4	15.4	15.4	15.4	15.4
Total Common Shares Outstanding	15.4	15.4	15.4	15.4	15.4	15.4
Working Capital	178.99	192.74	200.41	213.69	209.85	205.24
Book Value Per Share	15.15	15.58	15.45	15.32	14.97	14.62
Tangible Book Value	233.23	239.86	237.93	235.74	230.5	225.06
Tangible Book Value Per Share	15.14	15.58	15.45	15.31	14.97	14.61
Machinery	52.92	40.5	30.25	30.41	26	37.44
Leasehold Improvements	0.11	0.11	0.11	-	-	4.45

Source: S&P Global Market Intelligence. Standard template. Financial Sources.